Ikaros-Notch axis in host hematopoietic cells regulates experimental graft-versus-host disease.

Host hematopoietically derived APCs play a vital role in the initiation of GVH responses. However, the APC autonomous molecular mechanisms that are critical for the induction of GVHD are not known. We report here that the Ikaros-Notch axis in host hematopoietically derived APCs regulates the severity of acute GVHD across multiple clinically relevant murine models of experimental bone marrow transplantation. In the present study, Ikaros deficiency (Ik(-/-)) limited to host hematopoietically derived APCs enhanced donor T-cell expansion and intensified acute GVHD, as determined by survival and other GVHD-specific parameters. The Ik(-/-) conventional CD8(+) and CD8(-)CD11c(+) dendritic cells (DCs), the most potent APCs, showed no increase in the expression of activation markers or in response to TLR stimulation compared with wild-type controls. However, Ik(-/-) DCs demonstrated an enhanced stimulation of allogeneic T cells. Deficiency of Ikaros in the conventional CD8(+) and CD8(-)CD11c(+) DCs was associated with an increase in Notch signaling, the blockade of which mitigated the enhanced in vitro and in vivo allostimulatory capacity. Therefore, the Ikaros-Notch axis is a novel pathway that modulates DC biology in general, and targeting this pathway in host hematopoietically derived APCs may reduce GVHD.

[1]  W. Pear,et al.  Notch signaling is a critical regulator of allogeneic CD4+ T-cell responses mediating graft-versus-host disease. , 2009, Blood.

[2]  J. Redondo,et al.  Alternative promoter usage at the Notch1 locus supports ligand-independent signaling in T cell development and leukemogenesis. , 2010, Immunity.

[3]  W. Zou,et al.  A Crucial Role for Host APCs in the Induction of Donor CD4+CD25+ Regulatory T Cell-Mediated Suppression of Experimental Graft-versus-Host Disease , 2010, The Journal of Immunology.

[4]  S. Winandy,et al.  Notch Target Gene Deregulation and Maintenance of the Leukemogenic Phenotype Do Not Require RBP-Jκ in Ikaros Null Mice , 2010, The Journal of Immunology.

[5]  C. Guidos,et al.  Functions of notch signaling in the immune system: consensus and controversies. , 2010, Annual review of immunology.

[6]  D. Gabrilovich,et al.  Regulation of dendritic cell differentiation and function by Notch and Wnt pathways , 2010, Immunological reviews.

[7]  R. Arceci.  Deletion of IKZF1 and Prognosis in Acute Lymphoblastic Leukemia , 2010 .

[8]  D. Hanauer,et al.  New perspectives on the biology of acute GVHD , 2010, Bone Marrow Transplantation.

[9]  Jiangwen Zhang,et al.  Genome-wide lineage-specific transcriptional networks underscore Ikaros-dependent lymphoid priming in hematopoietic stem cells. , 2009, Immunity.

[10]  Raphael Kopan,et al.  The Canonical Notch Signaling Pathway: Unfolding the Activation Mechanism , 2009, Cell.

[11]  K. Akashi,et al.  Plasmacytoid dendritic cells prime alloreactive T cells to mediate graft-versus-host disease as antigen-presenting cells. , 2009, Blood.

[12]  S. Winandy,et al.  Cutting Edge: Ikaros Is a Regulator of Th2 Cell Differentiation1 , 2009, The Journal of Immunology.

[13]  M. Nolte,et al.  Inflammatory signals in dendritic cell activation and the induction of adaptive immunity , 2009, Immunological reviews.

[14]  Iannis Aifantis,et al.  γ-secretase inhibitors reverse glucocorticoid resistance in T cell acute lymphoblastic leukemia , 2009, Nature Medicine.

[15]  Laurence Bugeon,et al.  Cutting Edge: Notch Signaling Induces a Distinct Cytokine Profile in Dendritic Cells That Supports T Cell-Mediated Regulation and IL-2-Dependent IL-17 Production1 , 2008, The Journal of Immunology.

[16]  S. Winandy,et al.  Ikaros Regulates Notch Target Gene Expression in Developing Thymocytes1 , 2008, The Journal of Immunology.

[17]  P. Kastner,et al.  Ikaros Represses the Transcriptional Response to Notch Signaling in T-Cell Development , 2008, Molecular and Cellular Biology.

[18]  C. Dinarello,et al.  Histone deacetylase inhibition modulates indoleamine 2,3-dioxygenase-dependent DC functions and regulates experimental graft-versus-host disease in mice. , 2008, The Journal of clinical investigation.

[19]  Christopher B. Miller,et al.  BCR–ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros , 2008, Nature.

[20]  Katie L. Kathrein,et al.  Ikaros Directly Represses the Notch Target Gene Hes1 in a Leukemia T Cell Line , 2008, Journal of Biological Chemistry.

[21]  J. Aster,et al.  Canonical notch signaling is dispensable for the maintenance of adult hematopoietic stem cells. , 2005, Cell stem cell.

[22]  Chunxia Chen,et al.  Ikaros Enforces the Costimulatory Requirement for IL2 Gene Expression and Is Required for Anergy Induction in CD4+ T Lymphocytes1 , 2007, The Journal of Immunology.

[23]  A. F. Campese,et al.  Notch and Ikaros: Not Only Converging Players in T Cell Leukemia , 2007, Cell cycle.

[24]  A. Thomson,et al.  Tolerogenic dendritic cells and the quest for transplant tolerance , 2007, Nature Reviews Immunology.

[25]  B. Reizis,et al.  Notch–RBP-J signaling controls the homeostasis of CD8− dendritic cells in the spleen , 2007, The Journal of experimental medicine.

[26]  M. Nussenzweig,et al.  CD8− DCs induce IL-12–independent Th1 differentiation through Delta 4 Notch-like ligand in response to bacterial LPS , 2007, The Journal of experimental medicine.

[27]  T. Banović,et al.  Effector and regulatory T-cell function is differentially regulated by RelB within antigen-presenting cells during GVHD. , 2007, Blood.

[28]  Christopher B. Miller,et al.  Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia , 2007, Nature.

[29]  A. F. Campese,et al.  Notch3 and the Notch3‐upregulated RNA‐binding protein HuD regulate Ikaros alternative splicing , 2007, The EMBO journal.

[30]  D. Gabrilovich,et al.  Regulation of dendritic-cell differentiation by bone marrow stroma via different Notch ligands. , 2007, Blood.

[31]  G. Trinchieri,et al.  Ikaros is required for plasmacytoid dendritic cell differentiation. , 2006, Blood.

[32]  P. Kastner,et al.  Notch Activation Is an Early and Critical Event during T-Cell Leukemogenesis in Ikaros-Deficient Mice , 2006, Molecular and Cellular Biology.

[33]  C. Reis e Sousa.  Dendritic cells in a mature age , 2006, Nature reviews. Immunology.

[34]  R. Korngold,et al.  A crucial role for antigen-presenting cells and alloantigen expression in graft-versus-leukemia responses , 2005, Nature Medicine.

[35]  W. Pear,et al.  Notch signaling is an important regulator of type 2 immunity , 2005, The Journal of experimental medicine.

[36]  Hans Clevers,et al.  Notch/γ-secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cells , 2005, Nature.

[37]  H. Hirai,et al.  Delta1-Notch3 interactions bias the functional differentiation of activated CD4+ T cells. , 2003, Immunity.

[38]  A. Capobianco,et al.  Perturbation of Ikaros isoform selection by MLV integration is a cooperative event in Notch(IC)-induced T cell leukemogenesis. , 2003, Cancer cell.

[39]  Jiang Zhu,et al.  APCs in the Liver and Spleen Recruit Activated Allogeneic CD8+ T Cells to Elicit Hepatic Graft-Versus-Host Disease1 , 2002, The Journal of Immunology.

[40]  L. Miele,et al.  The Notch Ligand Jagged-1 Is Able to Induce Maturation of Monocyte-Derived Human Dendritic Cells1 , 2002, The Journal of Immunology.

[41]  J-Z Qin,et al.  Jagged-1 mediated activation of notch signaling induces complete maturation of human keratinocytes through NF-κB and PPARγ , 2002, Cell Death and Differentiation.

[42]  Anjana Rao,et al.  Transcriptional Mechanisms Underlying Lymphocyte Tolerance , 2002, Cell.

[43]  J-Z Qin,et al.  Jagged-1 mediated activation of notch signaling induces complete maturation of human keratinocytes through NF-kappaB and PPARgamma. , 2002, Cell death and differentiation.

[44]  G. Liu,et al.  Distinct signals control the hematopoiesis of lymphoid-related dendritic cells. , 2000, Blood.

[45]  Li Wu,et al.  Pre–T Cell Receptor (Tcr) and Tcr-Controlled Checkpoints in T Cell Differentiation Are Set by Ikaros , 1999, The Journal of experimental medicine.

[46]  K. Georgopoulos,et al.  Ikaros sets thresholds for T cell activation and regulates chromosome propagation. , 1999, Immunity.

[47]  K. Georgopoulos,et al.  Cell-autonomous defects in dendritic cell populations of Ikaros mutant mice point to a developmental relationship with the lymphoid lineage. , 1997, Immunity.

[48]  A. Sharpe,et al.  Selective defects in the development of the fetal and adult lymphoid system in mice with an Ikaros null mutation. , 1996, Immunity.

[49]  K. Georgopoulos,et al.  A dominant mutation in the Ikaros gene leads to rapid development of leukemia and lymphoma , 1995, Cell.

[50]  A. Sharpe,et al.  The ikaros gene is required for the development of all lymphoid lineages , 1994, Cell.

[51]  R. Steinman,et al.  Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor , 1992, The Journal of experimental medicine.

[52]  D. Moore,et al.  Ikaros, an early lymphoid-specific transcription factor and a putative mediator for T cell commitment. , 1992, Science.